Microplate Screening for Apoptosis with Antibody to Single-Stranded DNA Distinguishes Anticancer Drugs from Toxic Chemicals
Open Access
- 1 April 2003
- journal article
- research article
- Published by Elsevier in SLAS Discovery
- Vol. 8 (2) , 185-190
- https://doi.org/10.1177/1087057103253326
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivoNature Medicine, 2002
- Development of a high throughput in vitro toxicity screen predictive of high acute in vivo toxic potentialToxicology in Vitro, 2001
- In vitro long-term cytotoxicity testing of 27 MEIC chemicals on Hep G2 cells and comparison with acute human toxicity dataToxicology in Vitro, 2001
- Identification of Apoptotic Cells by Formamide-induced DNA Denaturation in Condensed ChromatinJournal of Histochemistry & Cytochemistry, 2001
- Apoptosis and cancer chemotherapyCell and tissue research, 2000
- Apoptosis and cancer drug targetingJournal of Clinical Investigation, 1999
- Relationship of Mitotic Arrest and Apoptosis to Antitumor Effect of PaclitaxelJNCI Journal of the National Cancer Institute, 1996
- Monoclonal Antibody to Single-Stranded DNA Is a Specific and Sensitive Cellular Marker of ApoptosisExperimental Cell Research, 1996
- p53 and chemosensitivityNature Medicine, 1996
- Pleiotropic drug resistance and survival advantage in leukemic cells with diminished apoptotic responseInternational Journal of Cancer, 1994